Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2025)
Volitionrx (VNRX) posted Total Non-Current Liabilities of $31.0 million for Q3 2025, down 4.87% on a QoQ basis from $32.6 million in Q2 2025, and up 514.48% year-over-year from $5.0 million in Q3 2024.
Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
Volitionrx's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $31.0 million for Q3 2025.
- Quarterly Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $31.0 million (up 514.48% YoY) and the FY2024 annual result came in at $27.7 million, up 474.36% from the prior year.
- Total Non-Current Liabilities was $31.0 million for Q3 2025 at Volitionrx, down from $32.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $32.6 million in Q2 2025 and bottomed at $3.2 million in Q3 2023.
- A 5-year average of $13.9 million and a median of $8.7 million in 2021 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 58.45% — and 2025, when it surged 552.55%.
- Volitionrx's Total Non-Current Liabilities stood at $9.7 million in 2021, then plunged by 58.45% to $4.0 million in 2022, then advanced by 19.57% to $4.8 million in 2023, then surged by 474.36% to $27.7 million in 2024, then gained by 11.76% to $31.0 million in 2025.
- Business Quant data shows VNRX's Total Non-Current Liabilities at $31.0 million in Q3 2025, $32.6 million in Q2 2025, and $29.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30.98 Mn |
| Jun 30, 2025 | 32.56 Mn |
| Mar 31, 2025 | 29.27 Mn |
| Dec 31, 2024 | 27.72 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Dec 31, 2022 | 4.04 Mn |
| Mar 31, 2022 | 20.82 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | 8.77 Mn |
| Jun 30, 2021 | 8.56 Mn |
| Dec 31, 2020 | 9.80 Mn |
| Sep 30, 2019 | 2.73 Mn |
| Dec 31, 2018 | 3.02 Mn |